Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Editas Medicine to Present at Chardan’s 5th Annual Genetic Medicines Conference
-
uniQure to Participate in Multiple Upcoming Industry Conferences in October
-
Rocket Pharmaceuticals to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference
-
Sensorion to Attend Three Conferences in October 2021, Including the Cell & Gene Meeting on the Mesa
-
Flamingo Therapeutics to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
-
4D Molecular Therapeutics to Participate in Chardan’s 5th Annual Genetic Medicines Conference
-
4D Molecular Therapeutics to Participate in Chardan’s 5th Annual Genetic Medicines Conference
-
Arrowhead Pharmaceuticals to Participate in Upcoming October 2021 Conferences
-
MeiraGTx to Present at the Chardan 5th Annual Genetic Medicines Conference
-
MeiraGTx to Present at the Chardan 5th Annual Genetic Medicines Conference
-
Renovacor to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
-
NeuBase to Participate at the Chardan 5th Annual Genetic Medicines Conference
-
Taysha Gene Therapies to Participate in Upcoming October Investor Healthcare Conferences
-
Alnylam to Webcast Presentation at Chardan Virtual 5th Annual Genetic Medicines Conference
-
Moderna to Present at Chardan’s Virtual 5th Annual Genetic Medicines Conference
-
Cabaletta Bio to Present at the Chardan 5th Annual Genetic Medicines Conference
-
CRISPR Therapeutics to Participate in the Chardan’s 5th Annual Genetic Medicines Conference
-
ReCode Therapeutics Announces Participation in Upcoming October Investor Conferences
-
Cabaletta Bio to Present at the Chardan 5th Annual Genetic Medicines Conference
-
Arbutus to Participate in October Investor Conferences
-
Arbutus to Participate in October Investor Conferences
-
Gennao Bio to Participate in Chardan’s 5th Annual Genetic Medicines Conference
-
TScan Therapeutics to Participate in the Chardan 5th Annual Genetic Medicines Conference
-
Silence Therapeutics to Participate in Fireside Chat at the Chardan Virtual Genetic Medicines Conference
-
TScan Therapeutics to Participate in the Chardan 5th Annual Genetic Medicines Conference
-
Beam Therapeutics to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference
-
Beam Therapeutics to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference
-
WinVest Acquisition Corp. Announces Full Exercise of $15 Million Over-Allotment Option by Underwriters
-
WinVest Acquisition Corp. Announces Full Exercise of $15 Million Over-Allotment Option by Underwriters
-
Caribou Biosciences to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference
-
Dyne Therapeutics to Present at Chardan’s Virtual 5th Annual Genetic Medicines Conference
-
Dyne Therapeutics to Present at Chardan’s Virtual 5th Annual Genetic Medicines Conference
-
Intellia Therapeutics to Present at Chardan’s 5th Annual Genetic Medicines Conference
-
Passage Bio to Participate in Upcoming October Conferences
-
Passage Bio to Participate in Upcoming October Conferences
-
Omega Therapeutics to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
-
Verve Therapeutics to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference
-
Verve Therapeutics to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference
-
Solid Biosciences (SLDB) PT Lowered to $17 at Chardan Capital Markets, Keeps 'Buy' Rating Amid SGT-001 Data
-
Form 10-Q Chardan NexTech Acquisit For: Jun 30
-
Sio Gene Therapies to Participate in Upcoming Conferences
-
Synlogic (SYBX) Prices 15M Share Stock Offering at $3/sh
-
Synlogic Announces Pricing of Public Offering of Common Stock
-
Pacifico Acquisition Corp. Announces Closing of Over-Allotment Option in Connection With Its Initial Public Offering
-
Pacifico Acquisition Corp. Announces Closing of Over-Allotment Option in Connection With Its Initial Public Offering
-
Wave Life Sciences to Present at the Chardan Virtual Genetic Medicines Conference
-
Wave Life Sciences to Present at the Chardan Virtual Genetic Medicines Conference
-
Solid Biosciences to Participate at Upcoming Investor Conferences
-
UPDATE: Chardan Capital Markets Upgrades Forte Biosciences Inc. (FBRX) to Neutral
-
WinVest Acquisition Corp. Announces Closing of $100 Million Initial Public Offering

